Nicolas M. Barthelemy's most recent trade in Repligen Corp. was a trade of 1,800 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Repligen Corp. | Nicolas M. Barthelemy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 1,800 | 1,800 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Nicolas M. Barthelemy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 973 | 4,441 (0%) | 0% | 0 | Common Stock | |
| Repligen Corp. | Nicolas M. Barthelemy | Director | Purchase of securities on an exchange or from another person at price $ 125.45 per share. | 14 Jun 2024 | 1,200 | 4,668 (0%) | 0% | 125.5 | 150,540 | Common Stock |
| Repligen Corp. | Nicolas M. Barthelemy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 1,376 | 1,376 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Nicolas M. Barthelemy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 701 | 3,468 (0%) | 0% | 0 | Common Stock | |
| Repligen Corp. | Nicolas M. Barthelemy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 1,487 | 1,487 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Nicolas M. Barthelemy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 686 | 2,767 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Nicolas M. Barthelemy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.33 per share. | 21 Nov 2022 | 9,082 | 23,021 (0%) | 0% | 23.3 | 211,883 | Common Stock |
| Twist Bioscience Corp | Nicolas M. Barthelemy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2022 | 9,082 | 11,279 | - | - | Director Stock Option (right to buy) | |
| 908 Devices Inc | Nicolas M. Barthelemy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2022 | 1,379 | 0 | - | - | Restricted Stock Unit | |
| 908 Devices Inc | Nicolas M. Barthelemy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2022 | 1,379 | 15,379 | - | - | Common Stock, par value $0.001 | |
| Repligen Corp. | Nicolas M. Barthelemy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 1,298 | 1,298 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Nicolas M. Barthelemy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 534 | 2,081 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Nicolas M. Barthelemy | Director | Purchase of securities on an exchange or from another person at price $ 29.25 per share. | 11 May 2022 | 8,550 | 13,939 (0%) | 0% | 29.3 | 250,096 | Common Stock |
| Standard BioTools Inc | Nicolas M. Barthelemy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 20,993 | 0 | - | - | Stock Option (Right to Buy) | |
| Standard BioTools Inc | Nicolas M. Barthelemy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.74 per share. | 01 Apr 2022 | 20,993 | 204,077 (0%) | 0% | 3.7 | 78,514 | Common Stock |
| Twist Bioscience Corp | Nicolas M. Barthelemy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2022 | 3,491 | 5,389 (0%) | 0% | 0 | Common Stock | |
| Repligen Corp. | Nicolas M. Barthelemy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 128.18 per share. | 29 Oct 2021 | 1,285 | 3,192 (0%) | 0% | 128.2 | 164,711 | Common Stock |
| Repligen Corp. | Nicolas M. Barthelemy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2021 | 1,285 | 0 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Nicolas M. Barthelemy | Director | Sale of securities on an exchange or to another person at price $ 288.20 per share. | 29 Oct 2021 | 1,285 | 1,907 (0%) | 0% | 288.2 | 370,337 | Common Stock |
| Repligen Corp. | Nicolas M. Barthelemy | Director | Sale of securities on an exchange or to another person at price $ 288.19 per share. | 29 Oct 2021 | 360 | 1,547 (0%) | 0% | 288.2 | 103,748 | Common Stock |
| 908 Devices Inc | Nicolas M. Barthelemy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 2,455 | 2,455 | - | - | Stock Option (option to buy) | |
| 908 Devices Inc | Nicolas M. Barthelemy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 1,379 | 1,379 | - | - | Restricted Stock Unit | |
| Standard BioTools Inc | Nicolas M. Barthelemy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 15,402 | 15,402 | - | - | Stock Option (Right to Buy) | |
| Standard BioTools Inc | Nicolas M. Barthelemy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 10,342 | 178,084 (0%) | 0% | 0 | Common Stock | |
| Repligen Corp. | Nicolas M. Barthelemy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 1,151 | 1,151 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Nicolas M. Barthelemy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 457 | 1,907 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Nicolas M. Barthelemy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2021 | 2,500 | 0 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Nicolas M. Barthelemy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Mar 2021 | 2,500 | 167,742 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Nicolas M. Barthelemy | Director | Sale of securities on an exchange or to another person at price $ 177.61 per share. | 09 Feb 2021 | 5,000 | 1,898 (0%) | 0% | 177.6 | 888,035 | Common Stock |
| Twist Bioscience Corp | Nicolas M. Barthelemy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2021 | 5,000 | 9,573 | - | - | Director Stock Option (right to buy) | |
| Twist Bioscience Corp | Nicolas M. Barthelemy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.33 per share. | 09 Feb 2021 | 5,000 | 6,898 (0%) | 0% | 23.3 | 116,650 | Common Stock |
| Twist Bioscience Corp | Nicolas M. Barthelemy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 973 | 973 | - | - | Director Stock Option (right to buy) | |
| Twist Bioscience Corp | Nicolas M. Barthelemy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 486 | 1,898 (0%) | 0% | 0 | Common Stock | |
| 908 Devices Inc | Nicolas M. Barthelemy | Director | 22 Dec 2020 | 19,541 | 0 | - | - | Series E Preferred Stock | ||
| 908 Devices Inc | Nicolas M. Barthelemy | Director | 22 Dec 2020 | 19,541 | 19,541 | - | - | Common Stock, par value $0.001 | ||
| 908 Devices Inc | Nicolas M. Barthelemy | Director | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 22 Dec 2020 | 14,000 | 14,000 | - | 20 | 280,000 | Common Stock, par value $0.001 |
| 908 Devices Inc | Nicolas M. Barthelemy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2020 | 14,410 | 14,410 | - | - | Stock Option (option to buy) | |
| Repligen Corp. | Nicolas M. Barthelemy | Director | Sale of securities on an exchange or to another person at price $ 195.51 per share. | 09 Nov 2020 | 1,214 | 1,450 (0%) | 0% | 195.5 | 237,349 | Common Stock |